DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,992,739 | +0.8% | 8,032 | -2.5% | 0.01% | 0.0% |
| Q2 2023 | $1,976,160 | -7.8% | 8,234 | -3.1% | 0.01% | 0.0% |
| Q1 2023 | $2,142,524 | -3.2% | 8,501 | +2.0% | 0.01% | -12.5% |
| Q4 2022 | $2,212,276 | +2.8% | 8,335 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $2,153,000 | +5.7% | 8,335 | +3.7% | 0.01% | +28.6% |
| Q2 2022 | $2,037,000 | +6.1% | 8,035 | +22.8% | 0.01% | +16.7% |
| Q1 2022 | $1,919,000 | -13.8% | 6,542 | -3.3% | 0.01% | -14.3% |
| Q4 2021 | $2,225,000 | +20.8% | 6,764 | +11.8% | 0.01% | +16.7% |
| Q3 2021 | $1,842,000 | -8.3% | 6,050 | -19.2% | 0.01% | -14.3% |
| Q2 2021 | $2,009,000 | +55.3% | 7,485 | +30.2% | 0.01% | +40.0% |
| Q1 2021 | $1,294,000 | +5.0% | 5,749 | +3.7% | 0.01% | 0.0% |
| Q4 2020 | $1,232,000 | +5.4% | 5,544 | +2.1% | 0.01% | 0.0% |
| Q3 2020 | $1,169,000 | +21.8% | 5,428 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $960,000 | +33.5% | 5,428 | +4.5% | 0.00% | 0.0% |
| Q1 2020 | $719,000 | +3.5% | 5,196 | +14.8% | 0.00% | +33.3% |
| Q4 2019 | $695,000 | +10.0% | 4,527 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $632,000 | +4.6% | 4,377 | +3.5% | 0.00% | 0.0% |
| Q2 2019 | $604,000 | -0.2% | 4,227 | -7.8% | 0.00% | 0.0% |
| Q1 2019 | $605,000 | +27.9% | 4,583 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $473,000 | +11.6% | 4,583 | +17.6% | 0.00% | +50.0% |
| Q3 2018 | $424,000 | +10.1% | 3,898 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $385,000 | -5.6% | 3,898 | -6.5% | 0.00% | 0.0% |
| Q1 2018 | $408,000 | +10.9% | 4,167 | +5.2% | 0.00% | 0.0% |
| Q4 2017 | $368,000 | +16.1% | 3,962 | +7.3% | 0.00% | 0.0% |
| Q3 2017 | $317,000 | -5.1% | 3,693 | -6.7% | 0.00% | 0.0% |
| Q2 2017 | $334,000 | -1.2% | 3,957 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $338,000 | +9.7% | 3,957 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $308,000 | +13.7% | 3,957 | +14.4% | 0.00% | +100.0% |
| Q3 2016 | $271,000 | -22.3% | 3,460 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $349,000 | +6.4% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $328,000 | +2.2% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $321,000 | +8.8% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $295,000 | -0.3% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $296,000 | +0.7% | 3,460 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $294,000 | -1.0% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $297,000 | +12.9% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $263,000 | -3.3% | 3,460 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $272,000 | -20.9% | 3,460 | -24.5% | 0.00% | -50.0% |
| Q1 2014 | $344,000 | +6.2% | 4,585 | +9.3% | 0.00% | 0.0% |
| Q4 2013 | $324,000 | -5.5% | 4,195 | -22.7% | 0.00% | 0.0% |
| Q2 2013 | $343,000 | – | 5,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |